Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium.
Kaposi sarcoma (KS) is an angioproliferative tumor derived from endothelial cells in which tumor cells form aberrant vascular structures. Ephrin B2 and ephrin B4 (EphB4) are artery- and vein-specific proteins, respectively, with critical roles in vessel maturation. We investigated whether the disorganized KS vasculature was due to unbalanced expression of ephrin B2 and EphB4. Secondly, we wished to determine if human herpesvirus type 8 (HHV-8), the viral agent associated with KS, regulates ephrin B2 and EphB4. An arterial phenotype was observed in KS tissue and cell lines, as shown by abundant expression of ephrin B2 with little or no EphB4. Infection of venous endothelial cells with HHV-8 resulted in a phenotype switch from EphB4 to ephrin B2, similar to that seen with vascular endothelial growth factor (VEGF). The HHV-8 effect on ephrin B2 expression was reproduced with the HHV-8-specific viral G-protein-coupled receptor. We also showed that ephrin B2 expression is required for KS cell viability by knock down with siRNA. KS is the first example of a human tumor with a predominantly arterial phenotype. This predominance can be attributed to expression of HHV-8 proteins and their downstream effects. Ephrin B2 is thus an important novel factor in KS biology and a potential target for therapy.
Masood
Rizwan
R
Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Xia
Guangbin
G
Smith
D Lynne
DL
Scalia
Piergips
P
Still
Jonathan G
JG
Tulpule
Anil
A
Gill
Parkash S
PS
D001158:Arteries; D001706:Biopsy; D002455:Cell Division; D002470:Cell Survival; D002478:Cells, Cultured; D018920:Coculture Techniques; D017931:DNA Primers; D004730:Endothelium, Vascular / Q000166:cytology / Q000473:pathology*; D036388:Ephrin-B2 / Q000235:genetics*; D019288:Herpesvirus 8, Human / Q000502:physiology*; D006801:Humans; D017403:In Situ Hybridization; D010641:Phenotype; D034741:RNA, Small Interfering; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012514:Sarcoma, Kaposi / Q000473:pathology* / Q000821:virology; D012878:Skin Neoplasms / Q000473:pathology; D014471:Umbilical Veins; D014680:Veins
D017931:DNA Primers; D036388:Ephrin-B2; D034741:RNA, Small Interfering